|
2006P-0364:
Reformulation of Central Nervous System (CNS) Stimulant Drugs
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Document #
|
| Received Date
|
| Filed Date
|
| Submitter Code
|
| Submitter
|
| FR Date
|
| FR Page
|
| Comment Date
|
| Files
|
| Remarks
|
|
|
|
|
|
|
| CP1
|
| 08/31/2006
|
| 08/28/2006
|
| Health Professional
|
| J. Kulli, M.D.
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
| Signature:
|
| John C. Kulli, M.D.
|
|
|
|
|
| ACK1
|
| 08/31/2006
|
| 08/31/2006
|
| Federal Government
|
| FDA/DDMB to J. Kulli, M.D.
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
|
| Signature:
|
| Gloria Ortega
|
|
|
|
|
|
|
|
| EC1
|
| 09/05/2006
|
| 09/03/2006
|
| Individual Consumer
|
| Mr. Dave Lowe
|
|
|
|
|
|
|
|
|
|
|
|
|
| Signature:
|
| Lowe, Dave
|
|
|
|
|
| LET1
|
| 02/28/2007
|
| 02/28/2007
|
| Federal Government
|
| FDA to John C. Kulli, M.D.
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
|
| Signature:
|
| Jane A. Axelrad
|
|
|
|
|
|
|
|
|
Top | Up
Page last updated:
March 8, 2007
|
